APC c.6211A>G ;(p.I2071V)

Variant ID: 5-112177502-A-G

NM_000038.5(APC):c.6211A>G;(p.I2071V)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma.

Journal For Immunotherapy Of Cancer
Trujillo, Jonathan A JA; Luke, Jason J JJ; Zha, Yuanyuan Y; Segal, Jeremy P JP; Ritterhouse, Lauren L LL; Spranger, Stefani S; Matijevich, Karen K; Gajewski, Thomas F TF
Publication Date: 2019-11-08

Variant appearance in text: APC: 6211A>G; I2071V
PubMed Link: 31703593
Variant Present in the following documents:
  • 40425_2019_Article_780.pdf
View BVdb publication page